Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01949129 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

StatusRecruiting
PhasePhase 2/3
Started2013-04
View on ClinicalTrials.gov ↗
The ALL SCTped 2012 FORUM is a multinational, multi-centre, controlled, prospective phase III study for the therapy and therapy optimisation for children and adolescents with ALL in complete morphological remission (CR, less than 5% bone marrow blasts, no blasts in cerebrospinal fluid, no other extramedullary leukemia), who have an indication for HSCT with a myeloablative conditioning regimen. The stratification of patients in first and following remissions according to the individual transplantation modalities rests upon an indication for allogeneic HSCT and the availability of a suitable donor within the individual transplantation groups.

Amendment history 2 changes detected by DataLookout

2026-09-05
Primary completion pushed: 2025-06 → 2030-06-01
2026-09-05
Completion pushed: 2030-04 → 2030-06-01
Trial Details
NCT Number NCT01949129
Lead Sponsor St. Anna Kinderkrebsforschung
Collaborators: ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Conditions Acute Lymphoblastic Leukaemia
Enrollment 1,800 participants
Start Date 2013-04
Primary Completion 2030-06-01 (estimated)
Study Completion 2030-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-04